Evidence map›Paper›PMID 10790380›Full record

ArticleGenetics2000

Negligible genetic diversity of mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure.

J M Musser, A Amin, S Ramaswamy

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 140 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Review
  7. Antigenic Variation and Immune Escape in the MTBC.Advances in experimental medicine and biology · 2017
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Genomic insights into tuberculosis.Nature reviews. Genetics · 2014
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

J M MusserLaboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA. jmusser@niaid.nih.gov
A Amin
S Ramaswamy
Baylor College of Medicine · USNational Institute of Allergy and Infectious Diseases · US

Funding

GENETIC EPIDEMIOLOGY OF TUBERCULOSIS SUSCEPTIBILITYR01AI041168 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI GRAVISS, EDWARD A · 1997 to 2001
$1.0M
TUBERCULOSIS--DEVELOPMENT OF DNA BASED DIAGNOSTICSR01AI037004 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI MUSSER, JAMES MALLORY · 1994 to 1998
–
TUBERCULOSIS SPREAD IN DRUG USERSR01DA009238 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI MUSSER, JAMES MALLORY · 1995 to 1999
–
NIAID NIH HHS AI-37004NIAID NIH HHS AI-41168NIDA NIH HHS DA-09238
6 · The paper itself

Abstract

A common theme in medical microbiology is that the amount of amino acid sequence variation in proteins that are targets of the host immune system greatly exceeds that found in metabolic enzymes or other housekeeping proteins. Twenty-four Mycobacterium tuberculosis genes coding for targets of the host immune system were sequenced in 16 strains representing the breadth of genomic diversity in the species. Of the 24 genes, 19 were invariant and only six polymorphic nucleotide sites were identified in the 5 genes that did have variation. The results document the highly unusual circumstance that prominent M. tuberculosis antigenic proteins have negligible structural variation worldwide. The data are best explained by a combination of three factors: (i) evolutionarily recent global dissemination in humans, (ii) lengthy intracellular quiescence, and (iii) active replication in relatively few fully immunocompetent hosts. The very low level of amino acid diversity in antigenic proteins may be cause for optimism in the difficult fight to control global tuberculosis.

Indexed as

AcyltransferasesGenetic VariationAmino Acid SequenceAntigens, BacterialBacterial ProteinsGlycoproteinsHumansMolecular Sequence DataMycobacterium tuberculosisSequence Homology, Amino AcidTuberculosis19 kDa antigen, Mycobacterium45-47 kDa antigen complex, MycobacteriumAcyltransferasesantigen 85B, Mycobacterium tuberculosisantigen 85C, Mycobacterium tuberculosisAntigens, BacterialBacterial ProteinsGlycoproteinsMPB64 protein, Mycobacterium

Identifiers

PMID10790380
PMCPMC1461055
OpenAlexW2138474951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.